Athira Pharma, Inc., a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and slow neurodegeneration, announced the appointment of Javier San Martin, M.D., as Chief Medical Officer.
April 15, 2024
· 8 min read
